Results of PONDx, a prospective multicenter study of the Oncotype DX® breast cancer assay: Real-life utilization and decision impact in French clinical practice

Author:

Curtit Elsa,Vannetzel Jean-Michel,Darmon Jean-Claude,Roche Sophie,Bourgeois Hugues,Dewas Sylvain,Catala Stéphanie,Mereb Emile,Fanget Charlotte Furtos,Genet Dominique,Forest Anne-Marie,Bernier Céline,Pivot Xavier

Funder

Genomic Health

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference47 articles.

1. Les cancers en France, Les Données INCa,2016

2. St. Gallen international expert consensus on the primary therapy of early breast cancer;Curigliano,2017

3. Xu B. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen international expert consensus conference on the primary therapy of early breast cancer 2017;André;Ann Oncol,2017

4. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials;Peto;Lancet,2012

5. Prospective WSG phase III PlanB trial: clinical outcome at 5 year follow up and impact of 21 gene recurrence score result, central/local-pathological review of grade, ER, PR and Ki67 in HR+/HER2- high risk node-negative and -positive breast cancer;Gluz,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3